Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
AARP8 小时
25 Top Medicare Part D Drugs Have Nearly Doubled in Price
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
The American Journal of Managed Care5 小时
Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor
A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
Drugmakers raise US prices on over 250 medicines
NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...
nationthailand6 天
Drugmakers raised prices on 250+ medicines in the US starting Jan. 1
Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol ...
MM&M6 天
Big Pharma hikes prices of 250 drugs in January
Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...
pharmaphorum2 天
Merck/Pfizer undercut rivals with newly approved diabetes drug
Merck already has the world’s biggest selling oral treatment for type 2 diabetes, its DPP-4-based drugs Januvia and Janumet, but it is playing catch-up in the SGLT2 market. The monotherapy and ...
Malaysia Sun6 天
Pfizer, other drugmakers raise prices on more than 60 drugs
In 2023, drug companies launched new medications at prices 35 percent higher than the year before. On January 1, Pfizer ...